Johnathan M. Lancaster

Oncology
12902 Usf Magnolia Dr
Tampa, FL 33612

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications

Prevalence of viral DNA in high-grade serous epithelial ovarian cancer and correlation with clinical outcomes.

Prevalence of viral DNA in high-grade serous epithelial ovarian cancer and correlation with clinical outcomes.

Journal: PloS one
Published: July 08, 2023

Compassionate Use of REGEN-COV® in Patients With Coronavirus Disease 2019 (COVID-19) and Immunodeficiency-Associated Antibody Disorders.

Compassionate Use of REGEN-COV® in Patients With Coronavirus Disease 2019 (COVID-19) and Immunodeficiency-Associated Antibody Disorders.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: November 05, 2021

Utilizing digital pathology to quantify stromal caveolin-1 expression in malignant and benign ovarian tumors: Associations with clinicopathological parameters and clinical outcomes.

Utilizing digital pathology to quantify stromal caveolin-1 expression in malignant and benign ovarian tumors: Associations with clinicopathological parameters and clinical outcomes.

Journal: PloS one
Published: August 04, 2021

Economic impact of multigene panel testing for hereditary breast and ovarian cancer.

Economic impact of multigene panel testing for hereditary breast and ovarian cancer.

Journal: Journal of comparative effectiveness research
Published: January 25, 2021

Germline Pathogenic Variants in the Ataxia Telangiectasia Mutated (ATM) Gene are Associated with High and Moderate Risks for Multiple Cancers.

Germline Pathogenic Variants in the Ataxia Telangiectasia Mutated (ATM) Gene are Associated with High and Moderate Risks for Multiple Cancers.

Journal: Cancer prevention research (Philadelphia, Pa.)
Published: September 09, 2020

Family history of breast cancer in men with non-BRCA male breast cancer: implications for cancer risk counseling.

Family history of breast cancer in men with non-BRCA male breast cancer: implications for cancer risk counseling.

Journal: Breast cancer research and treatment
Published: July 30, 2020

Association of a Polygenic Risk Score With Breast Cancer Among Women Carriers of High- and Moderate-Risk Breast Cancer Genes.

Association of a Polygenic Risk Score With Breast Cancer Among Women Carriers of High- and Moderate-Risk Breast Cancer Genes.

Journal: JAMA network open
Published: July 02, 2020

Integrating Clinical and Polygenic Factors to Predict Breast Cancer Risk in Women Undergoing Genetic Testing.

Integrating Clinical and Polygenic Factors to Predict Breast Cancer Risk in Women Undergoing Genetic Testing.

Journal: JCO precision oncology
Published: June 24, 2020

Age of ovarian cancer diagnosis among BRIP1, RAD51C, and RAD51D mutation carriers identified through multi-gene panel testing.

Age of ovarian cancer diagnosis among BRIP1, RAD51C, and RAD51D mutation carriers identified through multi-gene panel testing.

Journal: Journal of ovarian research
Published: May 07, 2020

Development and Validation of a Clinical Polygenic Risk Score to Predict Breast Cancer Risk.

Development and Validation of a Clinical Polygenic Risk Score to Predict Breast Cancer Risk.

Journal: JCO precision oncology
Published: April 07, 2020

Letter to the Editor.

Letter to the Editor.

Journal: Journal of comparative effectiveness research
Published: November 20, 2019

Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast Cancer.

Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast Cancer.

Journal: Annals of surgical oncology
Published: May 10, 2019
Showing 1-12 of 50

Last Updated: 09/26/2026